Batch-to-batch consistency trial of an adenovirus type-5 vector-based COVID-19 vaccine in adults aged 18 years and above.

Zhuo-Pei LiYun-Feng ShiLi-Hua HouPeng-Fei JinShi-Hua MaHong-Xing PanJin-Long ZhangYong-Mei ShanHai-Tao HuangShi-Po WuPan DuXue WangLi-Li WangRui-Jie WangYing WangXue-Wen WangFeng-Cai ZhuJing-Xin Li

Published in: Expert review of vaccines (2022)

This trial was registered with ClinicalTrials.gov (NCT05313646).

Keyphrases

phase iii
study protocol
phase ii
coronavirus disease
clinical trial
sars cov
randomized controlled trial
open label
anaerobic digestion